These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 3258013

  • 1. Attenuation of MPTP-induced dopaminergic neurotoxicity by a serotonin uptake blocker.
    Brooks WJ, Jarvis MF, Wagner GC.
    J Neural Transm; 1988; 71(2):85-90. PubMed ID: 3258013
    [Abstract] [Full Text] [Related]

  • 2. Astrocytes as a primary locus for the conversion MPTP into MPP+.
    Brooks WJ, Jarvis MF, Wagner GC.
    J Neural Transm; 1989; 76(1):1-12. PubMed ID: 2785159
    [Abstract] [Full Text] [Related]

  • 3. Serotonergic conversion of MPTP and dopaminergic accumulation of MPP+.
    Shen RS, Abell CW, Gessner W, Brossi A.
    FEBS Lett; 1985 Sep 23; 189(2):225-30. PubMed ID: 3876242
    [Abstract] [Full Text] [Related]

  • 4. Effect of serotonergic, corticostriatal and kainic acid lesions on the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) in mice.
    Melamed E, Pikarski E, Goldberg A, Rosenthal J, Uzzan A, Conforti N.
    Brain Res; 1986 Dec 03; 399(1):178-80. PubMed ID: 3492237
    [Abstract] [Full Text] [Related]

  • 5. Dopamine-releasing action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridine (MPP+) in the neostriatum of the rat as demonstrated in vivo by the push-pull perfusion technique: dependence on sodium but not calcium ions.
    Sirinathsinghji DJ, Heavens RP, McBride CS.
    Brain Res; 1988 Mar 08; 443(1-2):101-16. PubMed ID: 3258784
    [Abstract] [Full Text] [Related]

  • 6. Age-dependent effects of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP).
    Jarvis MF, Wagner GC.
    Neuropharmacology; 1985 Jun 08; 24(6):581-3. PubMed ID: 3875054
    [Abstract] [Full Text] [Related]

  • 7. Dopamine but not norepinephrine or serotonin uptake inhibitors protect mice against neurotoxicity of MPTP.
    Melamed E, Rosenthal J, Cohen O, Globus M, Uzzan A.
    Eur J Pharmacol; 1985 Oct 08; 116(1-2):179-81. PubMed ID: 3876943
    [Abstract] [Full Text] [Related]

  • 8. Role for monoamine oxidase-A (MAO-A) in the bioactivation and nigrostriatal dopaminergic neurotoxicity of the MPTP analog, 2'Me-MPTP.
    Kindt MV, Youngster SK, Sonsalla PK, Duvoisin RC, Heikkila RE.
    Eur J Pharmacol; 1988 Feb 09; 146(2-3):313-8. PubMed ID: 3131149
    [Abstract] [Full Text] [Related]

  • 9. Participation of brain monoamine oxidase B form in the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: relationship between the enzyme inhibition and the neurotoxicity.
    Kinemuchi H, Arai Y, Toyoshima Y.
    Neurosci Lett; 1985 Jul 31; 58(2):195-200. PubMed ID: 3876524
    [Abstract] [Full Text] [Related]

  • 10. Mechanisms of MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity to striatal dopamine neurons in mice.
    Fuller RW, Hemrick-Luecke SK.
    Prog Neuropsychopharmacol Biol Psychiatry; 1985 Jul 31; 9(5-6):687-90. PubMed ID: 3878976
    [Abstract] [Full Text] [Related]

  • 11. Histochemistry of MPTP oxidation in the rat brain: sites of synthesis of the parkinsonism-inducing toxin MPP+.
    Nakamura S, Vincent SR.
    Neurosci Lett; 1986 Apr 24; 65(3):321-5. PubMed ID: 3487052
    [Abstract] [Full Text] [Related]

  • 12. Dopaminergic toxicity of rotenone and the 1-methyl-4-phenylpyridinium ion after their stereotaxic administration to rats: implication for the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity.
    Heikkila RE, Nicklas WJ, Vyas I, Duvoisin RC.
    Neurosci Lett; 1985 Dec 18; 62(3):389-94. PubMed ID: 3912685
    [Abstract] [Full Text] [Related]

  • 13. Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity.
    Javitch JA, D'Amato RJ, Strittmatter SM, Snyder SH.
    Proc Natl Acad Sci U S A; 1985 Apr 18; 82(7):2173-7. PubMed ID: 3872460
    [Abstract] [Full Text] [Related]

  • 14. Attenuation of MPTP-induced dopaminergic neurotoxicity by TV3326, a cholinesterase-monoamine oxidase inhibitor.
    Sagi Y, Weinstock M, Youdim MB.
    J Neurochem; 2003 Jul 18; 86(2):290-7. PubMed ID: 12871570
    [Abstract] [Full Text] [Related]

  • 15. Pharmacological properties of the MPTP analog trans-1-methyl-4-[4-dimethylaminophenylethenyl]-1,2,3,6-tetrahydropyridine and its pyridinium metabolite in mouse brain synaptosomes: a potential visual marker for substrates of MPTP-induced neurotoxicity.
    Klein BG, Kirby ML, Freeborn ER, Bloomquist JR.
    Prog Neuropsychopharmacol Biol Psychiatry; 2001 Apr 18; 25(3):591-608. PubMed ID: 11370999
    [Abstract] [Full Text] [Related]

  • 16. Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors.
    Heikkila RE, Manzino L, Cabbat FS, Duvoisin RC.
    Nature; 2001 Apr 18; 311(5985):467-9. PubMed ID: 6332989
    [Abstract] [Full Text] [Related]

  • 17. Prevention of dopaminergic toxicity of MPTP in mice by phenylethylamine, a specific substrate of type B monoamine oxidase.
    Melamed E, Youdim MB.
    Br J Pharmacol; 1985 Nov 18; 86(3):529-31. PubMed ID: 3877535
    [Abstract] [Full Text] [Related]

  • 18. The ex vivo effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on rat intra- and extraneuronal monoamine oxidase activity.
    Arai Y, Toyoshima Y, Kinemuchi H, Tadano T, Kisara K.
    Neurosci Lett; 1986 Oct 08; 70(2):266-71. PubMed ID: 3490638
    [Abstract] [Full Text] [Related]

  • 19. Mesencephalic dopamine neurons become less sensitive to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity during development in vitro.
    Danias P, Nicklas WJ, Ofori S, Shen J, Mytilineou C.
    J Neurochem; 1989 Oct 08; 53(4):1149-55. PubMed ID: 2788714
    [Abstract] [Full Text] [Related]

  • 20. On the mechanisms underlying 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity: the effect of perinigral infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, its metabolite and their analogs in the rat.
    Harik SI, Schmidley JW, Iacofano LA, Blue P, Arora PK, Sayre LM.
    J Pharmacol Exp Ther; 1987 May 08; 241(2):669-76. PubMed ID: 2437293
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.